Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 9395804, 14 pages
Research Article

Oxidative Medicine and Cellular Longevity Antioxidant and Antisenescence Effects of Bergamot Juice

1Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy
2Research Centre for Nutraceutical and Healthy Foods “Nutrafood”, University of Pisa, Via del Borghetto 80, 56124 Pisa, Italy
3Department of Science, University of Basilicata, Viale dell’Ateneo Lucano 10, 85100 Potenza, Italy

Correspondence should be addressed to Eleonora Da Pozzo; ti.ipinu@ozzopad.aronoele

Received 22 February 2018; Revised 28 April 2018; Accepted 29 May 2018; Published 12 July 2018

Academic Editor: Maura Palmery

Copyright © 2018 Eleonora Da Pozzo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Aging is one of the main risk factor for the onset of cardiovascular diseases; one of the possible explanations could be linked to the age-associated overproduction of free radicals. This increase of oxidative stress can be overcome with a high intake of food antioxidants. In this context, a number of studies have been addressed to assess the antiaging potential of natural antioxidant compounds. Recently, it has been shown that the juice of bergamot (Citrus bergamia Risso et Poiteau), a fruit mostly produced in the Ionian coastal areas of Southern Italy (Calabria), is a valuable source of health-promoting constituents with, among other, antioxidant properties. In order to investigate the potential antiaging effects of this Mediterranean natural antioxidant source, bergamot juices of three different cultivars (“fantastico,” “femminello,” and “castagnaro”) were herein characterized by the mean of high-performance liquid chromatography-photodiode array-electrospray ionization-tandem mass spectrometry. Then, juices were investigated for the evaluation of total polyphenolic and flavonoid contents, cell-free model antioxidant activities, and in vitro antiaging properties on two different cellular models of induced myocardial senescence. The best performing juice was also assessed in vivo. The phytochemical profiles confirmed that juices were rich in flavonoids, both flavone and flavanone glycosides. In addition, two limonoid glycosides were also identified in all cultivars. Each cultivar showed different phenolic and flavonoid contents. In tube results showed the juice robust antioxidant activities that correlate with their phenolic and flavonoid contents. Moreover, for the first time, the ability of juice to counteract the chemical-induced senescence was here demonstrated in both cellular models. Lastly, the in vivo data obtained from mouse hearts evidenced an increase in transcription of genes involved in antiaging and antioxidant responses. The overall results suggest that bergamot juice exerts antioxidant and antisenescence effects, making it useful for nutraceutical purposes.

1. Introduction

The pathogenesis of many age-associated diseases can be due to an increase of oxidative stress; indeed, the overproduction of free radicals could impair protein and fatty acid functions and could lead to DNA damage, predisposing to age-related disorders [1]. In particular, old age is a primary nonmodifiable risk factor for the onset of cardiovascular diseases. DNA damage and telomere shortening are associated with cellular senescence, atherosclerosis, coronary artery disease, and heart failure [2]. Furthermore, the accumulation of dysfunctional mitochondria in aged cardiomyocytes could alter the redox state and contribute to the pathological myocardial remodeling and heart failure [3].

In this line, a great deal of interest has been recently devoted to the antiaging potential of natural compounds with antioxidant properties [4]. Epidemiological studies have evidenced that a high intake of antioxidant-containing food is associated with a reduced risk of cardiovascular diseases. In particular, the Mediterranean diet (containing antioxidants, omega-3 and -6 polyunsaturated acids, polyphenols, flavonoids, and procyanidins) is associated with higher longevity and reduced risk of age-related vascular disease development [5]. A number of human dietary intervention trials have shown improvements in vascular function following the consumption of foods with high flavonoid content [6, 7]. Among these foods, Citrus fruits have gained a high attention for their content of flavonoids and other beneficial components. In particular, bergamot (Citrus bergamia Risso et Poiteau), a fruit mostly produced in the Ionian coastal areas of Southern Italy (Calabria), has been demonstrated to be a valuable source of health-promoting molecules that contribute to its antioxidant, anti-inflammatory, and cholesterol reduction capacities [817]. C. bergamia is a small tree; it belongs to the Rutaceae family, mainly cultivated in a specific area of Calabria, characterized by a microclimate suitable for its growth. Whereas the bergamot essential oil obtained from the fruit peel is extensively characterized [1820] and used in cosmetic and food industries, only recently the bergamot by-products, such as the pulp and its juice, were evaluated for their healthy biological properties [8, 11, 2125]. This reevaluation could represent an economic advantage in the industrial processes, reducing costs of their disposal and gaining a good source of beneficial compounds. Furthermore, the promotion of the bergamot fruit may have important economic implications for the regions in which this fruit can be cultivated.

To the best of our knowledge, no studies investigating antisenescence property of bergamot juice have been performed so far. Thus, in order to explore the potential cardiovascular antiaging effects of this natural antioxidant source, bergamot juices of three different cultivars (“fantastico,” “femminello,” and “castagnaro,” usually used in the industry) were herein characterized by the means of high-performance liquid chromatography-photodiode array-electrospray ionization-tandem mass spectrometry (HPLC-PDA-ESI-MS/MS). Then, the juices were investigated for the evaluation of total polyphenolic (TPC) and flavonoid (TFC) contents and for the cell-free model antioxidant activities by superoxide radical scavenging activity (O2•−), ferric reducing antioxidant power (FRAP), and lipid peroxidation inhibition (β-carotene bleaching, BCB) tests; finally, the relative antioxidant capacity index (RACI) was calculated. In vitro antiaging properties were tested on two different cellular models of chemical-induced senescence of myocardial cell line H9c2 derived from rat hearts. Lastly, the best performing juice was also assessed in vivo.

2. Materials and Methods

2.1. Chemicals and Apparatus

Solvents such as methanol, chloroform, phosphoric acid, hydrochloric acid, and glacial acetic acid were purchased from Carlo Erba (Milano, Italy). N,N-dimethylformamide (DMF) was obtained from Alfa Aesar (Karlsruhe, Germany). Acetonitrile HPLC grade were purchased from VWR (Milano, Italy). HPLC grade water (18 mΩ) was prepared by a Mill-Q purification system (Millipore Corp., Bedford, MA, USA). Dimethyl sulfoxide (DMSO), doxorubicin (DOX), hydrogen peroxide (H2O2), p-formaldehyde, Folin-Ciocalteu reagent 2 N, sodium carbonate, aluminum chloride, sodium nitrate, sodium nitroprusside (SNP), sulfanilamide, N-(1-naphthyl) ethylenediamine dihydrochloride, phenazine methosulphate (PMS), β-nicotinamide adenine dinucleotide (NADH), nitrotetrazolium blue chloride (NBT), potassium phosphate monobasic (KH2PO4), sodium acetate trihydrate, 2,4,6-tripyridyl-s-triazine (TPTZ), iron(III) chloride (FeCl3·6H2O), β-carotene, linoleic acid, Tween 20, sodium hydroxide, gallic acid, quercetin, naringin, ascorbic acid, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), butylhydroxytoluen (BHT, 2,6-bis (1,1-dimethylethyl)-4-methylphenol), Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), penicillin, and streptomycin were purchased from Sigma-Aldrich (Milano, Italy). CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay (MTS) was obtained from Promega Italia Srl (Milano, Italy).

All spectrophotometric measurements were done in cuvettes or 96-well microplates on a UV/vis spectrophotometer (SPECTROstar Nano, BMG LABTECH).

2.2. Plant Material

Three different cultivars of C. bergamia (“fantastico,” “femminello,” and “castagnaro”) were supplied by Young Fruit and Visalli Diego companies (Reggio Calabria, Italy). Fresh fruits of each cultivar were squeezed using a manual citrus juicer, and the obtained juices were stored at −20°C and defrosted to room temperature before analyses.

2.3. Sample Preparation

For HPLC-PDA-ESI-MS study, 10.0 mL of each juice was added to DMF (10.0 mL) and the mixture was centrifuged three times for 5 min at 1145 ×g. The supernatant liquid was filtered through a 3 mm diameter PTFE membrane with a 0.45 μm pore size. Aliquots of 10 μL were injected into the LC-MS system.

For the evaluation of TPC, TFC, and antioxidant activities, juices were lyophilized and then dissolved in methanol. For the assessment of antisenescence activity, lyophilized juices were dissolved in DMSO. The samples were sonicated and centrifuged.

2.4. HPLC-PDA-ESI-MS/MS Analyses

Qualitative HPLC-PDA-ESI-MS/MS analyses were performed using a Surveyor LC pump, a Surveyor autosampler, coupled with a Surveyor PDA detector, and a LCQ Advantage ion trap mass spectrometer (Thermo Finnigan) equipped with Xcalibur 3.1 software. Analysis was performed using a 4.6 × 150 mm, 4 μm, Synergi Fusion-RP column (Phenomenex). The eluent was a mixture of acetonitrile (solvent A) and water (solvent B). The solvent gradient was as follows: 0–15 min 5–20%, 15–40 min 20–70% A, and 40–45 min 70–100% A. Elution was performed at a flow rate of 0.8 mL/min with a splitting system of 2 : 8 to the MS detector (160 μL/min) and PDA detector (640 μL/min), respectively. The volume of the injected juice DMF solutions was 10 μL. Analyses were performed with an ESI interface in the negative mode. The ionization conditions were optimized, and the parameters used were as follows: capillary temperature, 210°C; capillary voltage, −10.0 V; tube lens offset, −50.0 V; sheath gas flow rate, 60.00 arbitrary units; auxiliary gas flow rate, 20.00 arbitrary units; spray voltage, 4.50 kV; and scan range of m/z 150–1200. In the MS/MS experiments, normalized collision energy 35.0% was applied. N2 was used as the sheath and auxiliary gas. PDA data were recorded with 200–600 nm range with two preferential channels as the detection wavelength 280 and 325 nm. In order to determine the amount of main bergamot juice flavonoids, calibration curve was constructed by using the naringin as external standard in a concentration range 0.0020–0.25 mg/mL and DMF as solvent. Six different concentrations of standard solutions (0.250, 0.125, 0.060, 0.030, 0.0075, and 0.002 mg/mL) were prepared and analysed by triplicate injections. The calibration curve was generated by using concentration (mg/mL) with respect to the area obtained from the integration of the PDA/UV peaks recorded at 325 nm. The relation between variables was analyzed using linear simple correlation. For the linear regression of the standard, was 0.9997. The flavonoid amounts were obtained by using a GraphPad Software Prism 6.0 and finally expressed as mg/mL of fresh juice.

2.5. Total Polyphenol Content

Folin-Ciocalteu assay was used to determine the total polyphenol content of samples [26]. Distilled water (425 μL) and 75 μL of the diluted sample (methanol in blank) were added to 500 μL of Folin-Ciocalteu reagent and 500 μL of Na2CO3 (10% w/v). The mixture was mixed and incubated for 1 h in the dark at room temperature. The absorbance was measured at 723 nm after incubation. Gallic acid was used as standard, and results were expressed as mg gallic acid equivalents per gram of the dried sample (mg GAE/g) from three independent assays.

2.6. Total Flavonoid Content

One hundred μL of each sample (methanol in blank) was added to 15 μL of 5% NaNO3 into the microcentrifuge tube. After 5 min, 30 μL of 10% AlCl3 was added; after some minutes, 100 μL of 1 M NaOH solution and 255 μL of distilled water were added. The absorbance was measured against blank at 510 nm after 10 min of incubation at room temperature. Quercetin was used as standard, and the total flavonoid content was expressed as mg of quercetin equivalents per gram of the dried sample (mg QE/g) from three independent assays [27].

2.7. In Tube Activity
2.7.1. Superoxide Radical (O2•−) Scavenging Activity

Superoxide radicals (O2•−) were generated in the PMS/NADH system, as previously reported [28]. The reaction mixture consisted of 40 μL of different concentrations of the sample (methanol in negative control), 40 μL of NADH, and 130 μL of NBT. The reaction was started by adding of PMS (40 μL) to the mixture. The superoxide scavenging capacity of methanol samples was quantified by their ability to inhibit NBT reduction to blue formazan by superoxide. The assay was conducted at room temperature, and the absorbance of formazan produced was determined at 560 nm for 2 min in kinetic function. Results were expressed in mg/mL as concentration of the sample required to inhibit the activity by 50% (IC50) from three independent assays. Ascorbic acid was used as positive control.

2.7.2. Ferric Reducing Antioxidant Power

The ferric reducing antioxidant power of samples was determined using FRAP assay with some modifications [29]. Briefly, 25 μL of appropriately diluted sample (methanol in blank) was added to 225 μL of FRAP reagent and incubated at 37°C for 40 min in the dark. FRAP reagent was prepared fresh before experiment by mixing 300 mM acetate buffer in distilled water pH 3.6, 20 mM FeCl3·6H2O in distilled water, and 10 mM TPTZ in 40 mM HCl in a proportion of 10 : 1 : 1. The reduction of a colorless ferric complex (Fe3+-tripyridyltriazine) to a blue-colored ferrous complex (Fe2+-tripyridyltriazine) by action of electron-donating antioxidants was determined at 593 nm. Trolox was used as standard, and FRAP values were expressed as mg of Trolox equivalents per gram of the dried sample (mg TE/g) from three independent assays.

2.7.3. Lipid Peroxidation Inhibition Assay

The ability of samples to prevent the inhibition of lipid peroxidation was carried out by BCB assay as reported by Dekdouk et al. [26]. A stock solution of β-carotene/linoleic acid was made by dissolving 0.2 mg of β-carotene in 0.2 mL of chloroform, linoleic acid (20 mg), and Tween 20 (200 mg). The chloroform was completely removed by a rotary evaporator, and distilled water (50 mL) was added with oxygen. The resulting emulsion was vigorously stirred. Aliquots (950 μL) of the mixture were transferred to test tubes containing 50 μL of the sample (the final concentration for all tested samples was 0.25 mg/mL) or methanol as blank. BHT was used as a positive standard. 250 μL of this solution was transferred to a 96-well plate, and outer wells were filled with 250 μL of water to provide a large thermal mass because the reaction was temperature-sensitive. The microplate was immediately placed at 50°C for 180 min, and the absorbance was monitored at 470 nm every 30 min. Results, from three independent assays, were expressed as percentage of antioxidant activity (% AA) measured on the basis of BCB inhibition and calculated as follows:

2.7.4. RACI Calculation

To get a complete and dynamic picture of the ranking of food antioxidant capacity, the relative antioxidant capacity index was calculated. Previous data confirmed that RACI is a valid tool to assess food antioxidant capacity [30]. RACI was calculated by integrating the antioxidant capacity values generated from the different cell-free model methods.

2.8. In Vitro Activity
2.8.1. Cell Culture

H9c2 cells (normal primary cardiomyocytes; ATTC, Manassas, VA, USA) were cultured, following the usual procedures, in DMEM supplemented with 10% FBS, 100 units/mL penicillin, and 100 mg/mL streptomycin in tissue culture flasks at 37°C in a humidified atmosphere of 5% CO2.

2.8.2. Cell Viability

H9c2 cells were seeded at a density of 10 × 103 cells/cm2 in 96-well plates. “Fantastico” bergamot juice was dissolved in DMSO at a concentration of 100 mg/mL (stock preparation). After 24 h, the cells were treated for three days with fresh growth medium containing the lyophilized “fantastico” bergamot juice dissolved in DMSO, ranging from 0.01 to 1 mg/mL (DMSO 0.01%), or vehicle. Cell viability was then determined using the MTS assay according to manufacturer’s instruction. The absorbance of formazan at 490 nm was measured in a colorimetric assay with an automated plate reader from three independent assays (Victor Wallac 2, Perkin Elmer).

2.8.3. Senescence-Associated β-Galactosidase Staining

Cell senescence in H9c2 cells was induced by DOX or H2O2, as previously reported [31, 32]. Briefly, cells were cultured up to about 80% confluence in DMEM medium; before the experiments, cells were seeded onto 24-well plates at a density of 10 × 103 cells/cm2. After time to allow the cell attachment (24 h), the medium was replaced in each well and the cells received different treatments for 3 h, H2O2 (ranging from 5 to 100 μM), DOX (0.01, 0.05, and 0.1 μM), or relative vehicles. Subsequently, the cells were cultured for 3 days, after which senescence was determined.

To evaluate the number of senescent cells after 3 days from DOX or H2O2 insults, the senescence marker sa-β-Gal was detected as previously reported [33]. In parallel experiments, different concentrations of lyophilized “fantastico” bergamot juice dissolved in DMSO (0.01, 0.1 and 1 mg/mL) or vehicle (0.01% DMSO) were added to the cell medium after the DOX or H2O2 senescence insults and maintained in the medium for three days before assessing the sa-β-Gal staining. According to the literature, treated cells were fixed in p-formaldehyde and incubated in a dry incubator in freshly prepared staining solution for 16 h at 37°C [34]. Cells were then washed in phosphate-buffered saline (PBS) (1x) and photographed at 100x magnification. Images of random light microscopic fields were captured (5 fields per well), and both blue and total cells were counted using ImageJ (ImageJ Software, version 1.41, USA). Three independent assays were performed.

2.9. In Vivo Activity
2.9.1. Chronic Treatment

C57BL/6J mice were taken from Envigo (Milan, Italy). All procedures were performed according to European (EEC Directive 2010/63) and Italian (D.L. 4 March 2014 n. 26) legislation. Animals were housed in cages with free access to standard food pellets and water on a 12 h light/dark cycle.

Nine-month-old male mice (25–30 g) were randomly assigned into two groups: one group was used as a control while the other group received lyophilized “fantastico” bergamot juice diluted in water (1 mg/kg/day). The final concentration of the lyophilized juice was 1 mg/mL, and the diluted solution was daily prepared. Mice were weekly weighed, and water intake was daily monitored over a period of three months. At the end of treatment, mice were fasted overnight to measure blood glucose levels. Blood was collected from the tail tip, and glucose concentration was determined using the Glucocard™ blood glucose meter (Menarini). Then, mice were anaesthetized with an intraperitoneal injection of aqueous urethane solution 30% w/w (Sigma-Aldrich). Intracardiac blood was collected in tubes with the anticoagulant EDTA (BD Vacutainer), in order to measure the complete lipid panel (tryglicerides, total cholesterol, HDL, and LDL) and glycated haemoglobin (using cobas b 101 instrument, Roche Diagnostics). Finally, hearts were taken, and an amount was immediately processed to extract the total RNA, in order to assess three genes relevant to aging, lifespan, and antioxidant response (SIRT1, NRF2, FOXO3, HO-1, and NQO1).

2.9.2. RNA Extraction and Real-Time PCR Analysis

Total RNA from mouse hearts was extracted using the RNeasy® Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. Purity of the RNA samples was determined by measuring the absorbance at 260 : 280 nm. cDNA synthesis was performed with 500 ng of RNA using the i-Script cDNA synthesis kit (Bio-Rad, Hercules, USA) following the manufacturer’s instructions. Primers used for RT-PCR were designed in intron/exon boundaries to ensure that products did not include genomic DNA (Table 1) [3537]. RT-PCR reactions consisted of 25 μL Fluocycle® II SYBR® (EuroClone, Milan, Italy), 1.5 μL of both 10 μM forward and reverse primers for SIRT1, NRF2, FOXO3, HO-1, NQO1, and GAPDH (Sigma-Aldrich, Milan, Italy), 3 μL cDNA, and 19 μL of H2O. All reactions were performed for 38 cycles using the following temperature profiles: 94°C for 30 s (initial denaturation); Annealing temperature °C (see Table 1) for 30 s (annealing); and 72°C for 1 s (extension). GAPDH was used as the housekeeping gene. mRNA levels for each sample were normalized against GAPDH mRNA levels, and relative expression was calculated by using the Ct value. PCR specificity was determined by both the melting curve analysis and gel electrophoresis.

Table 1: Nucleotide sequences, annealing temperature, and product size of the primers utilized in real-time RT-PCR experiments.
2.10. Statistical Analyses

The nonlinear multipurpose curve-fitting program GraphPad Prism (GraphPad Software Inc., San Diego, CA) was used for data analysis and graphic presentations. The cell-free model antioxidant activity data were expressed as mean ± standard deviation of three independent experiments. Pearson coefficient was used to determine the correlation among polyphenol and flavonoid contents and antioxidant activity. The in vitro antisenescence activity data are presented as the means ± standard errors of the means (SEM) of triplicate samples and are representative of three different experiments. Statistical analysis was performed by one-way analysis of variance (ANOVA) with Bonferroni’s corrected -test for post hoc pair-wise comparisons. was considered statistically significant.

3. Results and Discussion

3.1. Juice Composition

In the present study, the HPLC-PDA profiles recorded at 325 nm of the three C. bergamia juices obtained from the different cultivars are displayed in Figure 1.

Figure 1: HPLC-PDA profiles of C. bergamia juices from “fantastico” (a), “femminello” (b), and “castagnaro” (c) cultivars. Peaks were monitored at 325 nm. For the peak data, see Table 2.

Compounds 114 were detected in all cultivars and were identified comparing their HPLC elution orders, ESI-MS/MS, and UV data (Table 2) with those previously reported.

Table 2: Spectral (UV and ESI-MS/MS), chromatographic data of compounds 114, detected in C. bergamia juices from “fantastico,” “femminello,” and “castagnaro” cultivars.a

In agreement with previous studies, our investigation about the chemical composition of bergamot juices led to identification of citric acid (1) [38], the flavonoids vicenin-2 (2), lucenin-2 4-methyl ether (3), neoeriocitrin (4), naringin (8), neohesperidin (9), 3-hydroxy-3-methylglutaryl-neoeriocitrin (10), neodiosmin/chrysoeriol 7-O-neohesperidoside (11), melitidin (12), and brutieridin (13) [39, 40]. The ESI-MS/MS technique has been useful for the identification of components that can occur as isomers in the Citrus juice. In particular, compound 4 was distinguished by its isomer eriocitrin due to its fragmentation pattern in which the base peak is represented by product ion at m/z 459 instead of m/z 287, as observed in the MS/MS experiment of eriocitrin [39]. Similarly, the base peak generated by MS/MS analysis of compound 8 was observed at m/z 459, in agreement with the fragmentation pathway of naringin [39], whereas the isomer narirutin is characterized by a most abundant product ion at m/z 287 [41]. The obtained data confirmed the bergamot juice composition, well established in many previous studies demonstrating that it is rich in flavonoid constituents, including both flavone and flavanone glycosides [39].

In addition, herein, the two limonoids, limonin glucoside (5) and nomilinic acid glucoside (14), were also identified. Limonoids are a class of bitter components of bergamot fruits and are generally abundant in Citrus seeds, but they are also present in pulps, peels, and juices, as reported in a recent work [40].

Lastly, the peak at retention time () 21.62 min was generated by the coelution of two compounds (6 and 7) that have not been previously detected in C. bergamia. Compounds 6 and 7 remained not identified, but we tentatively hypothesized their structures basing on full MS and MS/MS spectra (Figure 2).

Figure 2: ESI-MS/MS spectra of compounds 6 and 7. ESI-MS/MS spectra of compound 6 at m/z 901 (a) and compound 7 at m/z 885 (b), performed in the negative ion mode. For the peak data, see Table 1.

Full spectrum of compound 6 displayed a deprotonated molecule [M−H] at m/z 901. The MS/MS product ion spectrum showed ions at m/z 757 generated by the loss of a 3-hydroxy-3-methylglutaryl moiety ([M−H−144]) and 595, resulting from the loss of a 3-hydroxy-3-methylglutaryl residue followed by one hexose molecule ([M−H−144−162]). The base peak ion at m/z 595 can be attributed to eriocitrin or neoeriocitrin, two flavanone O-glycoside isomers previously reported in C. bergamia juice [39]. A very similar fragmentation profile was shown by MS/MS of component 7, obtained at m/z 855, producing ions at m/z 741 ([M−H−144]) and 579 ([M−H−144−162]), leading to suppose that compound 7 can be a naringin or narirutin ([M−H] at m/z 579) with a hydroxy-3-methylglutaryl moiety and a hexose residue linked to the molecule.

The quantification of the main flavonoids detected in all sample juices was determined on the naringin basis by HPLC-PDA recorded at 325 nm. Results obtained from quantitative analysis are listed in Table 3.

Table 3: Quantitative amount (mg/L of fresh bergamot juice) of the main flavonoids detected in C. bergamia juices from “fantastico,” “femminello,” and “castagnaro” cultivars by HPLC-PDA analysis at 325 nm.a
3.2. Total Polyphenol and Flavonoid Content

TPC and TFC of juices obtained from “fantastico,” “femminello,” and “castagnaro” cultivars of C. bergamia fruits were then investigated. Each cultivar showed different phenolic and flavonoid contents (Table 4).

Table 4: Results of O2•−, FRAP, and BCB tests, beside TPC and TFC, of juices of C. bergamia fruits obtained from cultivars “fantastico,” “femminello,” and “castagnaro”. mg GAE/g = mg of gallic acid equivalents per gram of the dried sample; mg QE/g = mg of quercetin equivalents per gram of the dried sample; IC50 = concentration of the sample required to inhibit the activity by 50% in mg/mL; mg TE/g = mg of Trolox equivalents per gram of the dried sample; % AA = percentage of antioxidant activity at final concentration of 0.25 mg/mL.

In particular, TPC ranged from 8.77 ± 0.77 to 17.10 ± 1.34 mg GAE/g of the sample in “castagnaro” and “fantastico,” respectively. TFC, instead, varied from 6.51 ± 0.61 to 57.46 ± 3.20 mg QE/g of the sample again in “castagnaro” and “fantastico,” respectively. The values of TPC are in accordance with Sicari and Pellicanò [42], although in that case, fresh juice has been used as the sample, whereas here juices have been previously lyophilized.

3.3. In Tube Antioxidant Activity

In order to characterize the total antioxidant capacity of bergamot juices [27], four different and complementary assays were herein used to evaluate juice antioxidant activities. The samples were evaluated firstly for their antiradical activity against superoxide and nitric oxide physiological radicals. Then, samples were assessed for their abilities to reduce ferric ions and to inhibit the lipid peroxidation (Table 4). Two of the used tests (O2•− and FRAP) have not been previously reported for measuring the activity of bergamot juice samples. Last, the RACI was also calculated.

3.3.1. O2•− Scavenging Activity

O2•− is a radical oxygen species normally produced inside the body, but it is known to be very harmful to cellular components as a precursor of a more reactive oxygen species, for example, the hydroxyl radical. The activity of ascorbic acid (IC50 = 4.34 ± 0.39 mg/mL), used as reference, was compared with the samples by IC50 values (Table 4). Juice obtained from “castagnaro” exhibited the lowest IC50 value (IC50 = 1.01 ± 0.02 mg/mL), followed by “fantastico” (IC50 = 1.13 ± 0.11 mg/mL). Both these juices demonstrated to have a stronger superoxide radical scavenging activity than ascorbic acid. Juice obtained from “femminello” exhibited an activity (IC50 = 4.77 ± 0.58) similar to ascorbic acid. The scavenging activities were in accordance with previous investigation [10].

3.3.2. Ferric Reducing Antioxidant Power

FRAP test evaluates the ability of plant extracts to reduce ferric ions. In our study, the FRAP assay revealed that “fantastico” cultivar had the highest reducing power (9.83 ± 0.54 mg TE/g), followed by “femminello” and “castagnaro” (8.43 ± 0.67 and 6.85 ± 0.63 mg TE/g, respectively) (Table 4).

3.3.3. Lipid Peroxidation Inhibition Test

To get a wider overview of the antioxidant potential, the antioxidant effect of the samples on the peroxidation of linoleic acid in the β-carotene/linoleic acid system was also investigated by a BCB test. The oxidation of linoleic acid generates peroxyl free radicals, which will then oxidize the highly unsaturated β-carotene. The presence of antioxidants minimizes the oxidation of β-carotene. All samples showed moderate β-carotene bleaching inhibition activity; in fact, results ranged from 22.42 ± 1.15 to 31.60 ± 0.50 % and the highest value was found in cultivar “castagnaro” (Table 4).

3.3.4. Relative Antioxidant Capacity Index

Moreover, RACI was calculated among all the tested samples. All methods used for antioxidant activity determination together with TPC were included in RACI calculation. In particular, TPC assay results were included since it was recently proposed that the results obtained by the Folin-Ciocalteu procedure could be also interpreted as an alternative way to measure the total reducing capacity of samples as the reagent reacts with any reducing substance [26]. Results of antioxidant activity expressed as IC50 were converted in 1/IC50 before the RACI calculation, and data of relative antioxidant activity were represented as histograms (Figure 3).

Figure 3: RACI values obtained for the C. bergamia cultivars. RACI values were obtained comparing the total phenolic content, the superoxide radical scavenging activity, the ferric reducing antioxidant power, and the lipid peroxidation inhibition results of investigated cultivars.

According to the obtained results, “fantastico” cultivar had the highest RACI (0.55), followed by “castagnaro” (−0.09), and “femminello” (−0.45).

Recently, Sicari and Pellicanò [42] have investigated C. bergamia cultivar juices using two radical scavenging assays (2,2-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid, ABTS, and 1,1-diphenyl-2-picrylhydrazyl, DPPH). The highest antioxidant capacity has been found in “castagnaro” juice compared to “fantastico” and then “femminello”. On the contrary, comparing the radical scavenging activity of the three bergamot cultivars using just DPPH assay, the previous paper [39] has established “femminello” more active than “fantastico” and “castagnaro” cultivars.

These discrepancies among literature and in respect to present results may be ascribed to the fruit phenolic content that depends on many factors, such as the degree of maturity at harvest, genetic differences, and environmental conditions [42]. Notably, statistically significant differences on antioxidant activity and phenolic composition of bergamot fruits collected in different Calabria areas have been evidenced, suggesting that also the microclimate may influence the chemical composition and, therefore, the quality of the juice itself [11].

Then, in order to verify if there was a correlation between juice amount of polyphenols and antioxidant properties, Pearson analyses were conducted using averaged values of each variable, as reported in Table 5.

Table 5: Pearson coefficient calculated among TPC, TFC, superoxide radical scavenging activity, ferric reducing antioxidant power, and lipid peroxidation inhibition.a

The highest positive correlation was observed between FRAP and TPC and TFC (), suggesting a consistent relationship between polyphenolic and flavonoid content and the ferric reducing antioxidant power.

On the other hand, it was not noticed a high value of correlation when O2•− and BCB were evaluated in comparison to phenolic and flavonoids content. This result could be possibly explained because these tests involved not only phenolic compounds [27]. Moreover, the BCB test mostly gives an indication of lipophilic active constituents, whereas TPC assay reports the levels of both lipophilic and hydrophilic phenols. These data could suggest the presence of minor lipophilic and/or not phenolic compounds acting synergistically to enhance the biological activity.

3.4. Antisenescence Activity
3.4.1. H9c2 Mitochondrial Metabolic Activity

Although from embryonal origin, H9c2 cells were found to be closer for energy metabolism features to normal primary cardiomyocytes, H9c2 cells have been successfully used as an in vitro model to simulate cardiac ischemia-reperfusion injury [43]. Moreover, this cell line is widely used as a successful cellular model for studies of myocardial pathophysiology including aging processes [31, 32].

As a first step, in order to assess if bergamot juice affected per se cellular life/death processes, the mitochondrial metabolic activity was explored in H9c2 cells by the use of a tetrazolium dye. The mitochondrial metabolic activity is a parameter conventionally used to estimate cellular proliferation and drug toxicity. Cells were treated with the lyophilized bergamot juice of “fantastico” cultivar, which showed the highest antioxidant potential and represent about 90% among the three cultivars. The results demonstrated that bergamot juice did not exert any cytotoxic effect on H9c2 cells (Figure 4). Indeed, no difference was observed in the mitochondrial metabolic activity following three days of treatment in samples compared to control.

Figure 4: Effects of C. bergamia “fantastico” cultivar juice on the mitochondrial oxidative metabolism activity. H9c2 cells were treated with three different concentrations of lyophilized juice, dissolved in DMSO, and the mitochondrial oxidative metabolism activity was examined.
3.4.2. H9c2 Cell Senescence Induction

H9c2 cell senescence was induced by cell exposure to exogenous oxidative insults (doxorubicin, DOX, or hydrogen peroxide, H2O2), as previously reported [31, 32, 34]. The presence of senescence-associated β-galactosidase (sa-β-Gal) was monitored as a marker of cellular senescence. For chemical insults, in order to establish the effective dose of DOX or H2O2 able to induce cellular senescence, H9c2 cells were challenged with increasing concentrations of DOX (ranging from 0.01 to 0.1 μM) or H2O2 (ranging from 5 to 100 μM), diluted in water, for 3 h. Subsequently, the cells were cultured with fresh complete medium for 3 days, and then the presence of sa-β-Gal was examined. A concentration-dependent increase of sa-β-gal was observed following the H9c2 cell treatment with DOX (0.05 μM, and 0.1 μM, ). Conversely, only 60 μM H2O2 was effective to induce the staining of sa-β-Gal significantly (). A higher dose of H2O2 (100 μM) did not further increase the senescence marker, probably due to the cytotoxic effect exerted by such a high concentration of H2O2. Together, these results allowed us to establish 0.05 μM DOX and 60 μM H2O2 as the effective drug concentrations to be used for the following H9c2 cell experiments.

3.4.3. Effects of Bergamot Juice in Cellular Senescence Models

Therefore, with the aim to explore the protective potential of bergamot juice against cellular senescence, the DOX- or H2O2-treated cells were cultured with fresh complete medium containing different concentrations of “fantastico” bergamot juice (FBJ) and the pivotal senescence hallmark, the sa-β-Gal staining, was assessed after 3 days. Figure 5 showed the results obtained from the H2O2-induced (light gray bars) and DOX-induced (dark gray bars) senescence model.

Figure 5: Effects of C. bergamia “fantastico” juice on H9c2 senescence-associated β-galactosidase staining. (a) Representative phase contrast photomicrographs of control cells, DOX-injured cells, and DOX-injured cells treated with FBJ, 0.1 mg/mL. The arrows indicate the blue-stained cells. (b) Percentage of cellular senescence in not-injured cells treated with different concentrations of FBJ. Data are shown as the percentages of β-galactosidase-positive cells with respect to the total cell number of the sample. Each bar represents the mean ± SEM of three replicates from three independent experiments. (c) Percentage of cellular senescence in H2O2- or DOX-injured cells treated with FBJ at different concentrations. Data are shown as the percentages of β-galactosidase-positive cells with respect to the total cell number of the sample. Each bar represents the mean ± SEM of three replicates from three independent experiments. The light gray bars represent the data obtained from the H2O2-induced senescence model; the dark gray bars represent the data obtained from the DOX-induced senescence model. versus the control (cells not injured); versus the H2O2- or DOX-challenged cells with DMSO; versus the H2O2- or DOX-challenged cells with DMSO; versus the H2O2- or DOX-challenged cells with DMSO.

In Figure 5(a), representative phase contrast photomicrographs were reported, in which the sa-β-Gal staining cells are in light blue. As reported in Figure 5(b), bergamot juice alone did not affect the number of senescent cells with respect to control, for any of the tested concentrations. As expected, H9c2 cells injured with H2O2 or DOX evidenced a significant sa-β-Gal staining in respect of control cells (, versus control cells; Figure 5(c)), and notably, all the tested “fantastico” bergamot juice cotreatments were able to protect the injured cells from the appearing of the senescence hallmark ( and , ° versus H2O2 or DOX-treated cells; Figure 5(c)). Interestingly, in both cellular models, the relation between senescence percentages and FBJ concentrations showed an inversely proportional trend. These data suggested that the optimal FBJ concentration capable of better counteracting the senescence mechanism is the lowest one (0.01 mg/mL).

To the best of our knowledge, there is another study in the literature concerning the antisenescence potential of bergamot; this study has evidenced antiaging and immune modulating responses on human photoaged keratinocytes treated with a highly concentrated extract of bergamot fruit [44]. In addition, our results are in accordance with previous findings suggesting that the bergamot juice polyphenols could influence cellular function by acting as activators of sirtuin-1 [9], a nuclear histone deacetylase, largely involved in aging processes [45].

3.4.4. Effects of Bergamot Juice In Vivo

In light of the antisenescence results, “fantastico” juice effects were also assessed in old mice. During daily water intake of bergamot fruit juice, no difference between the “bergamot group” and the “vehicle group” was highlighted along the three months of treatment. Weekly weightings showed a physiological increase in the body mass, according to growth curves reported in the literature (data not shown). Blood total cholesterol, HDL, LDL, triglyceride, glycaemia, and glycated haemoglobin values were superimposable with the corresponding values measured in young-adult animals, suggesting that these animals did not have cardiometabolic diseases. Indeed, lipid and glycemic parameters measured in BFJ and control groups were not significantly different (Table 6).

Table 6: Lipid panel, glycaemia, and glycated haemoglobin levels (HbA1c) of treated mice.

Nevertheless, the real-time PCR analyses, performed on hearts of the old mice fed with FBJ or vehicle for three months, showed statistically significant increases in mRNA levels of three regulator genes, SIRT1, NRF2, and FOXO3, which are largely involved in antiaging and antioxidant responses (Figure 6).

Figure 6: FBJ induces gene expression. Real-time PCR analyses showed a statistically significant increase in SIRT1, NRF2, and FOXO3 mRNA levels in hearts of old mice fed with FBJ for three months. ; .

The silent information regulator 2 family proteins (SIRT), also called “sirtuins,” have been demonstrated to coordinate metabolic responses to changes in nutritional availability and maintain physiological homeostasis. Brain-specific Sirt1-overexpressing (BRASTO) transgenic mice have shown significant life span extension and delay in the aging process compared to control mice [46]. The nuclear factor erythroid 2-related factor 2 (NRF2) is a regulator of cellular resistance to oxidants; it orchestrates the expression of antioxidant response element-dependent genes to regulate the outcomes of oxidant exposure [47]. Last, forkhead/winged helix box gene, group O (FOXO) proteins are a set of transcription factors at a central integration hub for many important cellular pathways, relevant to healthy aging and longevity. FOXOs are involved in energy metabolism, oxidative stress, proteostasis, apoptosis, cell cycle regulation, metabolic processes, immunity, inflammation, and stem cell maintenance [48]. Notably, a BFJ-enriched diet was able to increase the mRNA expression of these three key genes in mice hearts, suggesting an enhanced cellular antioxidant capacity and an antiaging response for those mice fed with BFJ.

In order to further demonstrate the involvement of these pathways in the antioxidant effects of the active compounds contained in bergamot juice, two additional genes, NAD(P)H dehydrogenase quinine 1 (NQO1) and heme oxygenase 1 (HO-1), routinely assessed as markers of NRF2 activity, have been investigated. These two NRF2 target genes are markers of a robust antioxidant response [49]. As reported in Figure 7, the real-time PCR analyses, performed on hearts of the old mice fed with FBJ or vehicle for three months, showed statistically significant increases in mRNA levels of NQO1 and HO-1, suggesting a robust antioxidant effect for FBJ (Figure 7).

Figure 7: FBJ induces NQO1 and HO-1 gene expression. Real-time PCR analyses showed a statistically significant increase in NQO1 and HO-1 mRNA levels in hearts of old mice fed with FBJ for three months. ; .

Then, considering that oxidative stress has been pointed out as relevant cause of both in heart aging and in the development of several cardiac diseases, an approach with BFJ could guarantee an improvement of these targets (SIRT1, NRF2, FOXO, HO-1, and NQO1) typically altered and at the basis of cardiac dysfunction and of the consequent tissue damage [50].

Therefore, all together, these data indicated that the bergamot juice exerts beneficial health effects counteracting senescence in myocardial H9c2 cells and increases the antiaging and antioxidant defenses in mouse hearts, opening new perspectives on the potential pharmaceutical application of this natural source.

4. Conclusions

Natural polyphenols have gained considerable attention as potential agents for prevention and treatment of oxidative stress-related diseases, such as aging and cardiovascular diseases [5, 51], and in particular, the Mediterranean citrus fruit bergamot has been demonstrated to be a valuable source of antioxidant molecules. In addition, limonoids occurring in Citrus genus displayed different pharmacological activities; in particular, a placebo-controlled, double-blind study demonstrated that limonin glucoside may be useful in the prevention and/or treatment of different chronic inflammatory diseases, such as cancer, diabetes, and cardiovascular diseases [52]. The results of our study confirmed that bergamot juices possess a robust antioxidant activity and could be considered a valuable source of health-promoting constituents, such as naringin, neoeriocitrin, and neohesperidin, as previously established [11, 39, 41]. Furthermore, to the best of our knowledge, we demonstrated for the first time the potential of bergamot juice to counteract also the senescence processes, in vitro and in vivo.

These findings supported the nutraceutical properties of the bergamot fruit, encouraging the use of its pulp as health-promoting resource.

Data Availability

The data used to support the findings of this study are all included and available within the article.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this paper.

Authors’ Contributions

Eleonora Da Pozzo conceived the project, performed the cellular model experiments, and wrote the manuscript; Claudia Martini revised the manuscript; Marinella De Leo and Alessandra Braca performed HPLC-PDA-ESI-MS/MS analyses and revised the manuscript; Immacolata Faraone and Luigi Milella evaluated total polyphenolic and flavonoid contents, performed cell-free model antioxidant assays, and revised the manuscript. Chiara Cavallini performed the senescence assay and RT-PCR. Lara Testai and Eugenia Piragine performed animal experimentations. Vincenzo Calderone and Luisa Pistelli revised the manuscript.


This work was supported by the University of Pisa (Grant no. PRA_2017_26).


  1. N. Khansari, Y. Shakiba, and M. Mahmoudi, “Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer,” Recent Patents on Inflammation & Allergy Drug Discovery, vol. 3, no. 1, pp. 73–80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. C. Kovacic, P. Moreno, V. Hachinski, E. G. Nabel, and V. Fuster, “Cellular senescence, vascular disease, and aging: part 1 of a 2-part review,” Circulation, vol. 123, no. 15, pp. 1650–1660, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Shih, B. Lee, R. J. Lee, and A. J. Boyle, “The aging heart and post-infarction left ventricular remodeling,” Journal of the American College of Cardiology, vol. 57, no. 1, pp. 9–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. J. Ding, S. Q. Zheng, X. B. Huang et al., “Current perspective in the discovery of anti-aging agents from natural products,” Natural Products and Bioprospecting, vol. 7, no. 5, pp. 335–404, 2017. View at Publisher · View at Google Scholar
  5. R. R. Holt, C. Heiss, M. Kelm, and C. L. Keen, “The potential of flavanol and procyanidin intake to influence age-related vascular disease,” Journal of Nutrition in Gerontology and Geriatrics, vol. 31, no. 3, pp. 290–323, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Aviram, L. Dornfeld, M. Rosenblat et al., “Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice,” The American Journal of Clinical Nutrition, vol. 71, no. 5, pp. 1062–1076, 2000. View at Publisher · View at Google Scholar
  7. J. A. Vita, “Polyphenols and cardiovascular disease: effects on endothelial and platelet function,” The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 292S–297S, 2005. View at Publisher · View at Google Scholar
  8. V. Mollace, I. Sacco, E. Janda et al., “Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies,” Fitoterapia, vol. 82, no. 3, pp. 309–316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Risitano, M. Curro, S. Cirmi et al., “Flavonoid fraction of bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-κB inhibition in THP-1 monocytes,” PLoS One, vol. 9, no. 9, article e107431, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Ferlazzo, G. Visalli, A. Smeriglio et al., “Flavonoid fraction of orange and bergamot juices protect human lung epithelial cells from hydrogen peroxide-induced oxidative stress,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 957031, 14 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Sicari, M. R. Loizzo, V. Branca, and T. M. Pellicanò, “Bioactive and antioxidant activity from Citrus bergamia Risso (bergamot) juice collected in different areas of Reggio Calabria Province, Italy,” International Journal of Food Properties, vol. 19, no. 9, pp. 1962–1971, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Ferlazzo, S. Cirmi, G. Calapai, E. Ventura-Spagnolo, S. Gangemi, and M. Navarra, “Anti-inflammatory activity of Citrus bergamia derivatives: where do we stand?” Molecules, vol. 21, no. 10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Impellizzeri, G. Bruschetta, R. Di Paola et al., “The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease,” Clinical Nutrition, vol. 34, no. 6, pp. 1146–1154, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Impellizzeri, M. Cordaro, M. Campolo et al., “Anti-inflammatory and antioxidant effects of flavonoid-rich fraction of bergamot juice (BJe) in a mouse model of intestinal ischemia/reperfusion injury,” Frontiers in Pharmacology, vol. 7, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Barreca, G. Gattuso, E. Bellocco et al., “Flavanones: citrus phytochemical with health‐promoting properties,” BioFactors, vol. 43, no. 4, pp. 495–506, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Ferlazzo, G. Visalli, S. Cirmi et al., “Natural iron chelators: protective role in A549 cells of flavonoids-rich extracts of Citrus juices in Fe (3+)-induced oxidative stress,” Environmental Toxicology and Pharmacology, vol. 43, pp. 248–256, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Mannucci, M. Navarra, F. Calapai, R. Squeri, S. Gangemi, and G. Calapai, “Clinical pharmacology of Citrus bergamia: a systematic review,” Phytotherapy Research, vol. 31, no. 1, pp. 27–39, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Costa, P. Dugo, M. Navarra, V. Raymo, G. Dugo, and L. Mondello, “Study on the chemical composition variability of some processed bergamot (Citrus bergamia) essential oils,” Flavour and Fragrance Journal, vol. 25, no. 1, pp. 4–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Navarra, N. Ferlazzo, S. Cirmi et al., “Effects of bergamot essential oil and its extractive fractions on SH-SY5Y human neuroblastoma cell growth,” The Journal of Pharmacy and Pharmacology, vol. 67, no. 8, pp. 1042–1053, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Cirmi, C. Bisignano, G. Mandalari, and M. Navarra, “Anti-infective potential of Citrus bergamia Risso et Poiteau (bergamot) derivatives: a systematic review,” Phytotherapy Research, vol. 30, no. 9, pp. 1404–1411, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Delle Monache, P. Sanita, E. Trapasso et al., “Mechanisms underlying the anti-tumoral effects of Citrus bergamia juice,” PLoS One, vol. 8, no. 4, article e61484, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. A. R. Cappello, V. Dolce, D. Iacopetta et al., “Bergamot (Citrus bergamia Risso) flavonoids and their potential benefits in human hyperlipidemia and atherosclerosis: an overview,” Mini Reviews in Medicinal Chemistry, vol. 16, no. 8, pp. 619–629, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Currò, R. Risitano, N. Ferlazzo et al., “Citrus bergamia juice extract attenuates β-amyloid-induced pro-inflammatory activation of THP-1 cells through MAPK and AP-1 pathways,” Scientific Reports, vol. 6, no. 1, article 20809, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Ferlazzo, S. Cirmi, M. Russo et al., “NF-κB mediates the antiproliferative and proapoptotic effects of bergamot juice in HepG2 cells,” Life Sciences, vol. 146, pp. 81–91, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Gabriele, S. Frassinetti, L. Caltavuturo et al., “Citrus bergamia powder: antioxidant, antimicrobial and anti-inflammatory properties,” Journal of Functional Foods, vol. 31, pp. 255–265, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Dekdouk, N. Malafronte, D. Russo et al., “Phenolic compounds from Olea europaea L. possess antioxidant activity and inhibit carbohydrate metabolizing enzymes in vitro,” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 684925, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. M. F. Armentano, F. Bisaccia, R. Miglionico et al., “Antioxidant and proapoptotic activities of Sclerocarya birrea [(A. Rich.) Hochst.] methanolic root extract on the hepatocellular carcinoma cell line HepG2,” BioMed Research International, vol. 2015, Article ID 561589, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Russo, P. Valentão, P. Andrade, E. Fernandez, and L. Milella, “Evaluation of antioxidant, antidiabetic and anticholinesterase activities of Smallanthus sonchifolius Landraces and correlation with their phytochemical profiles,” International Journal of Molecular Sciences, vol. 16, no. 8, pp. 17696–17718, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Benedetto, M. D’Auria, M. Mecca et al., “Chemical and biological evaluation of essential oil from Saussurea costus (Falc.) Lipsch. from Garhwal Himalaya collected at different harvesting periods,” Natural Product Research, pp. 1–4, 2018. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Sun and S. A. Tanumihardjo, “An integrated approach to evaluate food antioxidant capacity,” Journal of Food Science, vol. 72, no. 9, pp. R159–R165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Spallarossa, P. Altieri, C. Aloi et al., “Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2,” American Journal of Physiology Heart and Circulatory Physiology, vol. 297, no. 6, pp. H2169–H2181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Dong, X. Xu, G. Li et al., “Bradykinin inhibits oxidative stress-induced cardiomyocytes senescence via regulating redox state,” PLoS One, vol. 8, no. 10, article e77034, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Costa, S. Bendinelli, P. Gabelloni et al., “Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor,” PLoS One, vol. 8, no. 8, article e72281, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Da Pozzo, B. Costa, C. Cavallini et al., “The citrus flavanone naringenin protects myocardial cells against age-associated damage,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 9536148, 12 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Y. Li, X. Yang, Q. D. Zhao et al., “Lipopolysaccharide promotes tumorigenicity of hepatic progenitor cells by promoting proliferation and blocking normal differentiation,” Cancer Letters, vol. 386, pp. 35–46, 2017. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Leiss, W. Salzberger, B. Jacobs et al., “MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus,” PLoS One, vol. 12, no. 7, article e0181015, 2017. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Crispino, F. Galindo Ramirez, M. Campioni et al., “In vivo genetic manipulation of inner ear connexin expression by bovine adeno-associated viral vectors,” Scientific Reports, vol. 7, no. 1, p. 6567, 2017. View at Publisher · View at Google Scholar · View at Scopus
  38. C. A. Ledesma-Escobar, F. Priego-Capote, and M. D. Luque de Castro, “Characterization of lemon (Citrus limon) polar extract by liquid chromatography-tandem mass spectrometry in high resolution mode,” Journal of Mass Spectrometry, vol. 50, no. 11, pp. 1196–1205, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Gattuso, D. Barreca, C. Caristi, C. Gargiulli, and U. Leuzzi, “Distribution of flavonoids and furocoumarins in juices from cultivars of Citrus bergamia Risso,” Journal of Agricultural and Food Chemistry, vol. 55, no. 24, pp. 9921–9927, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Russo, A. Arigò, M. L. Calabrò, S. Farnetti, L. Mondello, and P. Dugo, “Bergamot (Citrus bergamia Risso) as a source of nutraceuticals: limonoids and flavonoids,” Journal of Functional Foods, vol. 20, pp. 10–19, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. M. P. Rodríguez-Rivera, E. Lugo-Cervantes, P. Winterhalter, and G. Jerz, “Metabolite profiling of polyphenols in peels of Citrus limetta Risso by combination of preparative high-speed countercurrent chromatography and LC-ESI-MS/MS,” Food Chemistry, vol. 158, pp. 139–152, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. V. Sicari and T. M. Pellicanò, “Phytochemical properties and antioxidant potential from Citrus bergamia, Risso (bergamot) juice extracted from three different cultivars,” Journal of Applied Botany and Food Quality, vol. 89, pp. 171–175, 2016. View at Google Scholar
  43. A. V. Kuznetsov, S. Javadov, S. Sickinger, S. Frotschnig, and M. Grimm, “H9c2 and HL-1 cells demonstrate distinct features of energy metabolism, mitochondrial function and sensitivity to hypoxia-reoxygenation,” Biochimica et Biophysica Acta, vol. 1853, no. 2, pp. 276–284, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Nisticò, J. Ehrlich, M. Gliozzi et al., “Telomere and telomerase modulation by bergamot polyphenolic fraction in experimental photoageing in human keratinocytes,” Journal of Biological Regulators and Homeostatic Agents, vol. 29, no. 3, pp. 723–728, 2015. View at Google Scholar
  45. A. Satoh, L. Stein, and S. Imai, “The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity,” Handbook of Experimental Pharmacology, vol. 206, pp. 125–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Satoh, C. . S. Brace, N. Rensing et al., “Sirt 1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH,” Cell Metabolism, vol. 18, no. 3, pp. 416–430, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. Q. Ma, “Role of Nrf2 in oxidative stress and toxicity,” Annual Review of Pharmacology and Toxicology, vol. 53, no. 1, pp. 401–426, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. B. J. Morris, D. C. Willcox, T. A. Donlon, and B. J. Willcox, “FOXO3–a major gene for human longevity,” Gerontology, vol. 61, no. 6, article 515525, pp. 515–525, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Loboda, M. Damulewicz, E. Pyza, A. Jozkowicz, and J. Dulak, “Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism,” Cellular and Molecular Life Sciences, vol. 73, no. 17, pp. 3221–3247, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. D. R. Seals, V. E. Brunt, and M. J. Rossman, “Strategies for optimal cardiovascular aging,” American Journal of Physiology-Heart and Circulatory Physiology, 2018. View at Publisher · View at Google Scholar
  51. R. Blomhoff, “Dietary antioxidants and cardiovascular disease,” Current Opinion in Lipidology, vol. 16, no. 1, pp. 47–54, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. D. S. Kelley, Y. C. Adkins, S. J. Zunino et al., “Citrus limonin glucoside supplementation decreased biomarkers of liver disease and inflammation in overweight human adults,” Journal of Functional Foods, vol. 12, pp. 271–281, 2015. View at Publisher · View at Google Scholar · View at Scopus